# Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies

> **NCT00763932** · PHASE2 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 7 (actual)

## Conditions studied

- Pompe Disease Infantile-Onset
- Glycogen Storage Disease Type II

## Interventions

- **BIOLOGICAL:** Myozyme

## Key facts

- **NCT ID:** NCT00763932
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-06
- **Final completion:** 2006-07
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763932, "Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00763932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*